世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
ヒアルロン酸の原料市場。世界の業界動向、シェア、サイズ、成長、機会、そして2021-2026年の予測Hyaluronic Acid Raw Material Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global hyaluronic acid raw material market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping i... もっと見る
サマリーThe global hyaluronic acid raw material market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.Hyaluronic acid raw materials are the substances used for the manufacturing of the natural compound. The acid is naturally present in the eyes, hair, joints, nerves, cartilages and extracellular matrix in the skin. It can also be synthesized by fermenting wheat peptones, sugar and certain bacteria. These ingredients aid in supporting the functioning of the connective tissues and promoting collagen binding by building up the proteins and regulating water concentration in the skin. The topical application of the acid can assist in the regeneration of the skin and reduce inflammation. As a result, it finds extensive applications in the manufacturing of cosmetics, drug delivery systems, pharmaceuticals and nutritional supplements. Hyaluronic Acid Raw Material Market Trends: Significant growth in the pharmaceutical industry across the globe is of the key factors creating a positive outlook for the market. Hyaluronic acid acts as a viscoelastic and anti-surgical adhesion agent, which is widely used in ophthalmic, dermatological and orthopedic procedures as a mechanical barrier for tissue adherence. Moreover, the increasing demand for anti-wrinkle and anti-aging creams and solutions among the masses for cosmetic enhancements is providing a thrust to the market growth. Additionally, various technological advancements, such as the development of innovative solutions for targeted drug delivery and regenerative medicines, are acting as other growth-inducing factors. Healthcare providers are extensively using hyaluronic acid injections to provide lubrication, reduce inflammation and promote cartilage and bone growth in the joint. Other factors, including rising expenditure capacities of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global hyaluronic acid raw material market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region and application. Breakup by Application: Ophthalmology Cataract Surgery Aqueous Eye Drop Contact Lens Orthopedics Viscosupplements Bone Regeneration Dermatology Intradermal Dermal Filler Wound Healing Drug Delivery Medical Device Coating Surgical Adhesion Prevention Biomaterials and Implants Cell and Tissue Preservation Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Anika Therapeutics Inc., Contipro a.s., Galderma S.A., LG Chem Ltd., Lifecore Biomedical LLC (Landec Corporation), Sanofi S.A., Seikagaku Corporation, Smith & Nephew plc and Zimmer Biomet. Key Questions Answered in This Report: How has the global hyaluronic acid raw material market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global hyaluronic acid raw material market? What are the key regional markets? What is the breakup of the market based on the application? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global hyaluronic acid raw material market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Hyaluronic Acid Raw Material Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Application 6.1 Ophthalmology 6.1.1 Market Trends 6.1.2 Key Segments 6.1.2.1 Cataract Surgery 6.1.2.2 Aqueous Eye Drop 6.1.2.3 Contact Lens 6.1.3 Market Forecast 6.2 Orthopedics 6.2.1 Market Trends 6.2.2 Key Segments 6.2.2.1 Viscosupplements 6.2.2.2 Bone Regeneration 6.2.3 Market Forecast 6.3 Dermatology 6.3.1 Market Trends 6.3.2 Key Segments 6.3.2.1 Intradermal 6.3.2.2 Dermal Filler 6.3.2.3 Wound Healing 6.3.3 Market Forecast 6.4 Drug Delivery 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Medical Device Coating 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Surgical Adhesion Prevention 6.6.1 Market Trends 6.6.2 Market Forecast 6.7 Biomaterials and Implants 6.7.1 Market Trends 6.7.2 Market Forecast 6.8 Cell and Tissue Preservation 6.8.1 Market Trends 6.8.2 Market Forecast 7 Market Breakup by Region 7.1 North America 7.1.1 United States 7.1.1.1 Market Trends 7.1.1.2 Market Forecast 7.1.2 Canada 7.1.2.1 Market Trends 7.1.2.2 Market Forecast 7.2 Asia-Pacific 7.2.1 China 7.2.1.1 Market Trends 7.2.1.2 Market Forecast 7.2.2 Japan 7.2.2.1 Market Trends 7.2.2.2 Market Forecast 7.2.3 India 7.2.3.1 Market Trends 7.2.3.2 Market Forecast 7.2.4 South Korea 7.2.4.1 Market Trends 7.2.4.2 Market Forecast 7.2.5 Australia 7.2.5.1 Market Trends 7.2.5.2 Market Forecast 7.2.6 Indonesia 7.2.6.1 Market Trends 7.2.6.2 Market Forecast 7.2.7 Others 7.2.7.1 Market Trends 7.2.7.2 Market Forecast 7.3 Europe 7.3.1 Germany 7.3.1.1 Market Trends 7.3.1.2 Market Forecast 7.3.2 France 7.3.2.1 Market Trends 7.3.2.2 Market Forecast 7.3.3 United Kingdom 7.3.3.1 Market Trends 7.3.3.2 Market Forecast 7.3.4 Italy 7.3.4.1 Market Trends 7.3.4.2 Market Forecast 7.3.5 Spain 7.3.5.1 Market Trends 7.3.5.2 Market Forecast 7.3.6 Russia 7.3.6.1 Market Trends 7.3.6.2 Market Forecast 7.3.7 Others 7.3.7.1 Market Trends 7.3.7.2 Market Forecast 7.4 Latin America 7.4.1 Brazil 7.4.1.1 Market Trends 7.4.1.2 Market Forecast 7.4.2 Mexico 7.4.2.1 Market Trends 7.4.2.2 Market Forecast 7.4.3 Others 7.4.3.1 Market Trends 7.4.3.2 Market Forecast 7.5 Middle East and Africa 7.5.1 Market Trends 7.5.2 Market Breakup by Country 7.5.3 Market Forecast 8 SWOT Analysis 8.1 Overview 8.2 Strengths 8.3 Weaknesses 8.4 Opportunities 8.5 Threats 9 Value Chain Analysis 10 Porters Five Forces Analysis 10.1 Overview 10.2 Bargaining Power of Buyers 10.3 Bargaining Power of Suppliers 10.4 Degree of Competition 10.5 Threat of New Entrants 10.6 Threat of Substitutes 11 Price Analysis 12 Competitive Landscape 12.1 Market Structure 12.2 Key Players 12.3 Profiles of Key Players 12.3.1 AbbVie Inc. 12.3.1.1 Company Overview 12.3.1.2 Product Portfolio 12.3.1.3 Financials 12.3.1.4 SWOT Analysis 12.3.2 Anika Therapeutics Inc. 12.3.2.1 Company Overview 12.3.2.2 Product Portfolio 12.3.2.3 Financials 12.3.2.4 SWOT Analysis 12.3.3 Contipro a.s. 12.3.3.1 Company Overview 12.3.3.2 Product Portfolio 12.3.4 Galderma S.A. 12.3.4.1 Company Overview 12.3.4.2 Product Portfolio 12.3.5 LG Chem Ltd. 12.3.5.1 Company Overview 12.3.5.2 Product Portfolio 12.3.5.3 Financials 12.3.5.4 SWOT Analysis 12.3.6 Lifecore Biomedical LLC (Landec Corporation) 12.3.6.1 Company Overview 12.3.6.2 Product Portfolio 12.3.7 Sanofi S.A. 12.3.7.1 Company Overview 12.3.7.2 Product Portfolio 12.3.7.3 Financials 12.3.7.4 SWOT Analysis 12.3.8 Seikagaku Corporation 12.3.8.1 Company Overview 12.3.8.2 Product Portfolio 12.3.8.3 Financials 12.3.9 Smith & Nephew plc 12.3.9.1 Company Overview 12.3.9.2 Product Portfolio 12.3.9.3 Financials 12.3.9.4 SWOT Analysis 12.3.10 Zimmer Biomet 12.3.10.1 Company Overview 12.3.10.2 Product Portfolio 12.3.10.3 Financials
SummaryThe global hyaluronic acid raw material market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.Hyaluronic acid raw materials are the substances used for the manufacturing of the natural compound. The acid is naturally present in the eyes, hair, joints, nerves, cartilages and extracellular matrix in the skin. It can also be synthesized by fermenting wheat peptones, sugar and certain bacteria. These ingredients aid in supporting the functioning of the connective tissues and promoting collagen binding by building up the proteins and regulating water concentration in the skin. The topical application of the acid can assist in the regeneration of the skin and reduce inflammation. As a result, it finds extensive applications in the manufacturing of cosmetics, drug delivery systems, pharmaceuticals and nutritional supplements. Hyaluronic Acid Raw Material Market Trends: Significant growth in the pharmaceutical industry across the globe is of the key factors creating a positive outlook for the market. Hyaluronic acid acts as a viscoelastic and anti-surgical adhesion agent, which is widely used in ophthalmic, dermatological and orthopedic procedures as a mechanical barrier for tissue adherence. Moreover, the increasing demand for anti-wrinkle and anti-aging creams and solutions among the masses for cosmetic enhancements is providing a thrust to the market growth. Additionally, various technological advancements, such as the development of innovative solutions for targeted drug delivery and regenerative medicines, are acting as other growth-inducing factors. Healthcare providers are extensively using hyaluronic acid injections to provide lubrication, reduce inflammation and promote cartilage and bone growth in the joint. Other factors, including rising expenditure capacities of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global hyaluronic acid raw material market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region and application. Breakup by Application: Ophthalmology Cataract Surgery Aqueous Eye Drop Contact Lens Orthopedics Viscosupplements Bone Regeneration Dermatology Intradermal Dermal Filler Wound Healing Drug Delivery Medical Device Coating Surgical Adhesion Prevention Biomaterials and Implants Cell and Tissue Preservation Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Anika Therapeutics Inc., Contipro a.s., Galderma S.A., LG Chem Ltd., Lifecore Biomedical LLC (Landec Corporation), Sanofi S.A., Seikagaku Corporation, Smith & Nephew plc and Zimmer Biomet. Key Questions Answered in This Report: How has the global hyaluronic acid raw material market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global hyaluronic acid raw material market? What are the key regional markets? What is the breakup of the market based on the application? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global hyaluronic acid raw material market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Hyaluronic Acid Raw Material Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Application 6.1 Ophthalmology 6.1.1 Market Trends 6.1.2 Key Segments 6.1.2.1 Cataract Surgery 6.1.2.2 Aqueous Eye Drop 6.1.2.3 Contact Lens 6.1.3 Market Forecast 6.2 Orthopedics 6.2.1 Market Trends 6.2.2 Key Segments 6.2.2.1 Viscosupplements 6.2.2.2 Bone Regeneration 6.2.3 Market Forecast 6.3 Dermatology 6.3.1 Market Trends 6.3.2 Key Segments 6.3.2.1 Intradermal 6.3.2.2 Dermal Filler 6.3.2.3 Wound Healing 6.3.3 Market Forecast 6.4 Drug Delivery 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Medical Device Coating 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Surgical Adhesion Prevention 6.6.1 Market Trends 6.6.2 Market Forecast 6.7 Biomaterials and Implants 6.7.1 Market Trends 6.7.2 Market Forecast 6.8 Cell and Tissue Preservation 6.8.1 Market Trends 6.8.2 Market Forecast 7 Market Breakup by Region 7.1 North America 7.1.1 United States 7.1.1.1 Market Trends 7.1.1.2 Market Forecast 7.1.2 Canada 7.1.2.1 Market Trends 7.1.2.2 Market Forecast 7.2 Asia-Pacific 7.2.1 China 7.2.1.1 Market Trends 7.2.1.2 Market Forecast 7.2.2 Japan 7.2.2.1 Market Trends 7.2.2.2 Market Forecast 7.2.3 India 7.2.3.1 Market Trends 7.2.3.2 Market Forecast 7.2.4 South Korea 7.2.4.1 Market Trends 7.2.4.2 Market Forecast 7.2.5 Australia 7.2.5.1 Market Trends 7.2.5.2 Market Forecast 7.2.6 Indonesia 7.2.6.1 Market Trends 7.2.6.2 Market Forecast 7.2.7 Others 7.2.7.1 Market Trends 7.2.7.2 Market Forecast 7.3 Europe 7.3.1 Germany 7.3.1.1 Market Trends 7.3.1.2 Market Forecast 7.3.2 France 7.3.2.1 Market Trends 7.3.2.2 Market Forecast 7.3.3 United Kingdom 7.3.3.1 Market Trends 7.3.3.2 Market Forecast 7.3.4 Italy 7.3.4.1 Market Trends 7.3.4.2 Market Forecast 7.3.5 Spain 7.3.5.1 Market Trends 7.3.5.2 Market Forecast 7.3.6 Russia 7.3.6.1 Market Trends 7.3.6.2 Market Forecast 7.3.7 Others 7.3.7.1 Market Trends 7.3.7.2 Market Forecast 7.4 Latin America 7.4.1 Brazil 7.4.1.1 Market Trends 7.4.1.2 Market Forecast 7.4.2 Mexico 7.4.2.1 Market Trends 7.4.2.2 Market Forecast 7.4.3 Others 7.4.3.1 Market Trends 7.4.3.2 Market Forecast 7.5 Middle East and Africa 7.5.1 Market Trends 7.5.2 Market Breakup by Country 7.5.3 Market Forecast 8 SWOT Analysis 8.1 Overview 8.2 Strengths 8.3 Weaknesses 8.4 Opportunities 8.5 Threats 9 Value Chain Analysis 10 Porters Five Forces Analysis 10.1 Overview 10.2 Bargaining Power of Buyers 10.3 Bargaining Power of Suppliers 10.4 Degree of Competition 10.5 Threat of New Entrants 10.6 Threat of Substitutes 11 Price Analysis 12 Competitive Landscape 12.1 Market Structure 12.2 Key Players 12.3 Profiles of Key Players 12.3.1 AbbVie Inc. 12.3.1.1 Company Overview 12.3.1.2 Product Portfolio 12.3.1.3 Financials 12.3.1.4 SWOT Analysis 12.3.2 Anika Therapeutics Inc. 12.3.2.1 Company Overview 12.3.2.2 Product Portfolio 12.3.2.3 Financials 12.3.2.4 SWOT Analysis 12.3.3 Contipro a.s. 12.3.3.1 Company Overview 12.3.3.2 Product Portfolio 12.3.4 Galderma S.A. 12.3.4.1 Company Overview 12.3.4.2 Product Portfolio 12.3.5 LG Chem Ltd. 12.3.5.1 Company Overview 12.3.5.2 Product Portfolio 12.3.5.3 Financials 12.3.5.4 SWOT Analysis 12.3.6 Lifecore Biomedical LLC (Landec Corporation) 12.3.6.1 Company Overview 12.3.6.2 Product Portfolio 12.3.7 Sanofi S.A. 12.3.7.1 Company Overview 12.3.7.2 Product Portfolio 12.3.7.3 Financials 12.3.7.4 SWOT Analysis 12.3.8 Seikagaku Corporation 12.3.8.1 Company Overview 12.3.8.2 Product Portfolio 12.3.8.3 Financials 12.3.9 Smith & Nephew plc 12.3.9.1 Company Overview 12.3.9.2 Product Portfolio 12.3.9.3 Financials 12.3.9.4 SWOT Analysis 12.3.10 Zimmer Biomet 12.3.10.1 Company Overview 12.3.10.2 Product Portfolio 12.3.10.3 Financials
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（金属材料）の最新刊レポート
IMARC Services Private Limited.社の金属材料分野での最新刊レポート
本レポートと同じKEY WORD（hyaluronic acid）の最新刊レポートよくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
